These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


511 related items for PubMed ID: 28628912

  • 1. Liver Kinase B1/AMP-Activated Protein Kinase Pathway Activation Attenuated the Progression of Endotoxemia in the Diabetic Mice.
    Yang Y, Dong R, Hu D, Chen Z, Fu M, Wang DW, Xu X, Tu L.
    Cell Physiol Biochem; 2017; 42(2):761-779. PubMed ID: 28628912
    [Abstract] [Full Text] [Related]

  • 2. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Lu J, Xiang G, Liu M, Mei W, Xiang L, Dong J.
    Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
    [Abstract] [Full Text] [Related]

  • 3. Cinacalcet-mediated activation of the CaMKKβ-LKB1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy.
    Lim JH, Kim HW, Kim MY, Kim TW, Kim EN, Kim Y, Chung S, Kim YS, Choi BS, Kim YS, Chang YS, Kim HW, Park CW.
    Cell Death Dis; 2018 Feb 15; 9(3):270. PubMed ID: 29449563
    [Abstract] [Full Text] [Related]

  • 4. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
    Xu XH, Hu Q, Zhou LS, Xu LJ, Zou X, Lu FE, Yi P.
    Curr Med Sci; 2020 Jun 15; 40(3):530-538. PubMed ID: 32681256
    [Abstract] [Full Text] [Related]

  • 5. Metformin ameliorates endotoxemia-induced endothelial pro-inflammatory responses via AMPK-dependent mediation of HDAC5 and KLF2.
    Tian R, Li R, Liu Y, Liu J, Pan T, Zhang R, Liu B, Chen E, Tang Y, Qu H.
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun 01; 1865(6):1701-1712. PubMed ID: 31002870
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol via activation of LKB1-AMPK signaling suppresses oxidative stress to prevent endothelial dysfunction in diabetic mice.
    Hu M, Liu B.
    Clin Exp Hypertens; 2016 Jun 01; 38(4):381-7. PubMed ID: 27149559
    [Abstract] [Full Text] [Related]

  • 7. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
    Jiang SJ, Dong H, Li JB, Xu LJ, Zou X, Wang KF, Lu FE, Yi P.
    World J Gastroenterol; 2015 Jul 07; 21(25):7777-85. PubMed ID: 26167077
    [Abstract] [Full Text] [Related]

  • 8. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC, Yeh HH, Huang WL, Yan JJ, Lai WW, Su WP, Chen HH, Su WC.
    Am J Respir Cell Mol Biol; 2013 Aug 07; 49(2):241-50. PubMed ID: 23526220
    [Abstract] [Full Text] [Related]

  • 9. Effect of Shenzhu Tiaopi granule on hepatic insulin resistance in diabetic Goto-Kakizakirats via liver kinase B1/adenosine 5'-monophosphate/mammalian target of rapamycin signaling pathway.
    Yin Y, Fang Z, Wu Y, You L.
    J Tradit Chin Med; 2021 Feb 07; 41(1):107-116. PubMed ID: 33522203
    [Abstract] [Full Text] [Related]

  • 10. LKB1/AMPK inhibits TGF-β1 production and the TGF-β signaling pathway in breast cancer cells.
    Li NS, Zou JR, Lin H, Ke R, He XL, Xiao L, Huang D, Luo L, Lv N, Luo Z.
    Tumour Biol; 2016 Jun 07; 37(6):8249-58. PubMed ID: 26718214
    [Abstract] [Full Text] [Related]

  • 11. Antidiabetic Effect of Salvianolic Acid A on Diabetic Animal Models via AMPK Activation and Mitochondrial Regulation.
    Qiang G, Yang X, Shi L, Zhang H, Chen B, Zhao Y, Zu M, Zhou D, Guo J, Yang H, Zhang L, Du G.
    Cell Physiol Biochem; 2015 Jun 07; 36(1):395-408. PubMed ID: 25967977
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. AMPK inhibition blocks ROS-NFκB signaling and attenuates endotoxemia-induced liver injury.
    Guo Y, Zhang Y, Hong K, Luo F, Gu Q, Lu N, Bai A.
    PLoS One; 2014 Jun 07; 9(1):e86881. PubMed ID: 24475189
    [Abstract] [Full Text] [Related]

  • 14. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q, Liu Z, Jiang L, Liu M, Ma J, Yang C, Han L, Nan K, Liang X.
    Mol Med Rep; 2016 Mar 07; 13(3):2590-6. PubMed ID: 26847819
    [Abstract] [Full Text] [Related]

  • 15. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
    Kim Y, Lim JH, Kim MY, Kim EN, Yoon HE, Shin SJ, Choi BS, Kim YS, Chang YS, Park CW.
    J Am Soc Nephrol; 2018 Apr 07; 29(4):1108-1127. PubMed ID: 29330340
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cilostazol improves high glucose-induced impaired angiogenesis in human endothelial progenitor cells and vascular endothelial cells as well as enhances vasculoangiogenesis in hyperglycemic mice mediated by the adenosine monophosphate-activated protein kinase pathway.
    Tseng SY, Chao TH, Li YH, Liu PY, Lee CH, Cho CL, Wu HL, Chen JH.
    J Vasc Surg; 2016 Apr 07; 63(4):1051-62.e3. PubMed ID: 25595409
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Metformin and cancer.
    Vallianou NG, Evangelopoulos A, Kazazis C.
    Rev Diabet Stud; 2013 Apr 07; 10(4):228-35. PubMed ID: 24841876
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.